Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

First, clinical trial results only become material events after some form of disclosure to non-insiders. Results then become tradable information that impacts (or can impact) company valuation. The company must disclose material information to everyone at the same time. To the question of releasing to shareholders first, generally public releases are to everyone and not just shareholders.

To the general issue of public release before a release to a party in negotiations, shareholders and the general public have no higher or less right to potential material information. However, depending on what’s in the CDA binding confidentiality, a potential partner or licensee can receive non public information ahead of shareholders and general public. The CDA can bind all parties to non disclosure and in effect can make all under a CDA insiders.

Anyone thinking differently please add or correct.

If IPIX is in negotiations with a company for P, do they have to release results to shareholders before they release to the company that they are negotiating with? Could we get results and a partnership at the same time?